<DOC>
	<DOCNO>NCT00836719</DOCNO>
	<brief_summary>This study open label 6 month study . All subject treat Polyphenon E ( 400 mg EGCG twice day ) six month . The main outcome pilot phase safety . Secondary outcome change NAA level 6 month measure MR-spectroscopy . NAA level marker neuronal function . We think Polyphenon E protect neuron thus increase NAA level .</brief_summary>
	<brief_title>Safety Polyphenon E Multiple Sclerosis Pilot Study</brief_title>
	<detailed_description>Additional clinical data include change EDSS , MS functional composite cognitive testing .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Diagnosis MS McDonald criterion Relapsingremitting MS secondary progressive MS Stable therapy Copaxone , least six month prior inclusion study therapy six month subject refuse therapy . EDSS Score less equal 6.5 ( able walk 20 meter without rest ) Ages 18−60 . Leukocytes ≥3,000/µL Absolute neutrophil count ≥1,500/µL Platelets ≥100,000/µL Total bilirubin ≤local upper limit normal normal AST ( SGOT ) ALT ( SGPT ) normal serum Creatinine woman childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry duration study participation . Ability understand willingness sign write informed consent document . Willing drink one cup black tea two cup coffee per day , abstain drink green tea take supplement contain green tea green tea compound , duration investigation . MS relapse within 30 day prior enrollment . A primary progressive form MS . Previous treatment prior study entry follow : complete radiation ablation bone marrow antiCD4 antibody treatment ( Campath ) time ; mitoxantrone , cyclophosphamide , cyclosporin , Natalizumab immunomodulatory immunosuppressant therapy except Copaxone methylprednisone relapse within prior nine month . History renal liver disease . Consumption green tea supplement contain green tea tea extract within 30 day prior enrollment . Participants may participate clinical trial involve investigational agent study , within six month prior enrol study . history allergic reaction attribute compound similar chemical biologic composition Polyphenon E , tea , inactive ingredient present active placebo capsule , include gelatin . history allergic reaction gadolinium condition contraindicate MRI . Uncontrolled , clinicallyrelevant active illness ( aside MS ) include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Any condition would make subject , opinion investigator , unsuitable study . Inability complete baseline MRI scan . Pregnant breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>safety</keyword>
	<keyword>open label</keyword>
	<keyword>Polyphenon E</keyword>
	<keyword>EGCG</keyword>
	<keyword>NAA</keyword>
	<keyword>N-acetyl-aspartate</keyword>
	<keyword>MRI</keyword>
</DOC>